PLos One:使用便携式胸部X光检查的ICU患者增强气胸可视化

2018-12-24 xiangting MedSci原创

新型增强软件改善了气胸的检测;经验较少的阅片者中可以看到最大的改进。

出现气胸可以导致ICU患者的急剧恶化,因此对气胸进行快速并准确的检测至关重要。便携式胸部X光检查常用于排除气胸,但由于患者的仰卧位和内外部材料的覆盖而受到阻碍。此外,胸片的初始评估可以由相对缺乏经验的医生进行。因此,一种可以显著改善便携式X光检查气胸的工具将有助于患者治疗。这项研究目的是评估不同临床经验的阅片者使用便携式胸部X光对ICU患者检测/排除气胸时,一种新型增强软件在气胸检测上的临床应用。

206张便携式ICU胸部X光片,103个有气胸,使用和不使用增强软件进行处理,然后由5位不同阅片经验的阅片者进行评估。图像按不同的复杂程度进行分组。

4/5位阅片者的气胸检测平均AUC从0.846-0.957增加至0.88-0.971,其中经验最少的阅片者改善最大。阅片经验最长的阅片者没有显著变化。图像复杂度对解读结果没有影响。

新型增强软件改善了气胸的检测;经验较少的阅片者中可以看到最大的改进。

原始出处:

Julia Ley-Zaporozhan. Enhanced pneumothorax visualization in ICU patients using portable chest radiography. PLos One. 21 December 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
    2020-11-25 14701227m79暂无昵称

    学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
    2018-12-24 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=902213, encodeId=f1e890221318, content=学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐学习使我快乐学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习,学习使我快乐我爱学习的话了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b245183802, createdName=14701227m79暂无昵称, createdTime=Wed Nov 25 16:31:21 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1991373, encodeId=fa9a19913e3df, content=<a href='/topic/show?id=a29f188e133' target=_blank style='color:#2F92EE;'>#X光检查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18871, encryptionId=a29f188e133, topicName=X光检查)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Apr 25 12:56:00 CST 2019, time=2019-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1942854, encodeId=c42d19428549f, content=<a href='/topic/show?id=5244385233f' target=_blank style='color:#2F92EE;'>#可视化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38523, encryptionId=5244385233f, topicName=可视化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Jul 31 18:56:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790308, encodeId=a3531e90308b4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Tue May 28 01:56:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441842, encodeId=1a5c1441842c8, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595372, encodeId=566915953e20a, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Wed Dec 26 02:56:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356316, encodeId=df6235631643, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Dec 24 22:16:09 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356310, encodeId=29b0356310f7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Dec 24 20:38:59 CST 2018, time=2018-12-24, status=1, ipAttribution=)]
    2018-12-24 医者仁心5538

    学习了

    0

相关资讯

JAMA:单腔ICD植入用于无起搏器适应证患者一级预防优于双腔ICD

5月15日JAMA刊发的一项研究报告称,在接受可植入式埋藏式心律转复除颤器(ICD)用作一级预防的无起搏适应证患者人群中发现,与应用单腔ICD相比,双腔ICD没有表现出任何优势。 这项回顾性队列研究纳入了32,000余例美国患者,其植入单腔和双腔ICD患者的1年死亡率、心衰或全因住院率均未见显著差异。丹佛健康医学中心的Pamela N. Peterson博士及其同事报告称。然而,双腔ICD却存在

Eur Raidol:穿个刺竟然搞出了气胸?经皮穿刺肺活检后气胸的发生率、危险因子和临床意义的时变分析。

经皮肺穿刺活检是肺癌诊断的一种方法。早在数十年前就有人利用这种方法来诊断肺癌,但是由于受到当时各种条件的限制,像放射学、病理学、穿刺器械等,这种检查方法并没有在临床上得到较大的开展。本研究旨在评价经皮穿刺肺活检(PLB)后相关气胸时间依赖性发病率、危险因子和临床意义,并将结果发表在Eur Raidol上。

JAMA Pediatr:针吸治疗新生儿气胸的效果优于胸腔引流

研究认为针吸对新生儿气胸的治疗效果优于胸腔引流,是经放射学证实的气胸患儿的首选治疗方案

这样的气胸不少见,胸腔穿刺需谨慎!

居然还有慢性气胸,你是在逗我么?

NEJM:胸腔镜技术与肺萎缩

一名46岁肝病终末期的女士,近来频繁地出现反复性肝性胸水和呼吸困难症状,我们对其行胸腔穿刺术治疗。在胸部检查中,右侧胸部听诊未闻及呼吸音。X线检查结果发现,右侧胸部存在液气胸(图A:箭头所指处为气胸;星号所示为胸腔积液)。我们通过猪尾导管将胸水引流出来,但气胸的问题并未能得到解决(图B所示处)。在计算机断层扫描(CT)中,结果显示右侧肺已萎缩和右侧胸膜脏层增厚,没有发现有支气管梗阻的迹象(如图C所

Chest:猪尾导管与胸导管作为气胸初次治疗的疗效比较!

由此可见,该荟萃分析的结果表明PC引流可作为原发性或继发性自发性气胸患者的首选治疗方案。理想的情况下,需要进行随机对照试验来比较PC与LBCT对不同气胸患者亚组间的疗效。